Literature DB >> 10621537

The pathogenesis of pterygia.

M T Coroneo1, N Di Girolamo, D Wakefield.   

Abstract

Pterygium is an active, invasive, inflammatory process, a key feature of which is focal limbal failure. In a two-stage process, "conjunctivalization" of the cornea occurs with tissue characterized by extensive chronic-inflammation, cellular proliferation, connective tissue remodeling, and angiogenesis. An understanding of this process has resulted in efforts aimed at limbal reconstruction, which is considered the gold standard for surgical care. Although good results have been obtained with other treatment methods, a long-term approach to follow-up with at least 5-year survival figures is desirable. Sophisticated analyses of the tear film and surface epithelium in patients with pterygium may help explain symptoms. The efficacy, at least in the short term, of nonsteroidal anti-inflammatory drugs in the treatment of inflamed pterygia has been confirmed. Corneal topographic analysis has shown that surgery reduces induced astigmatism and also causes subtle changes that may explain postsurgical improvements in vision.

Entities:  

Mesh:

Year:  1999        PMID: 10621537     DOI: 10.1097/00055735-199908000-00011

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  59 in total

1.  The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium.

Authors:  Timothy M Nolan; Nick DiGirolamo; Nitin H Sachdev; Taline Hampartzoumian; Minas T Coroneo; Denis Wakefield
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

2.  Proliferative and migratory aptitude in pterygium.

Authors:  Haiqing Bai; Yufei Teng; Lee Wong; Vishal Jhanji; Chi-Pui Pang; Gary Hin-Fai Yam
Journal:  Histochem Cell Biol       Date:  2010-10-12       Impact factor: 4.304

3.  Expression of p63 and p16 in primary and recurrent pterygia.

Authors:  Fernando S Ramalho; Claudia Maestri; Leandra N Z Ramalho; Alfredo Ribeiro-Silva; Erasmo Romão
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-08       Impact factor: 3.117

4.  Human papillomavirus and pterygium. Is the virus a risk factor?

Authors:  Nicolai Christian Sjö; Christian von Buchwald; Jan Ulrik Prause; Bodil Norrild; Troels Vinding; Steffen Heegaard
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

5.  Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up.

Authors:  Iraklis Vastardis; Bojan Pajic; Richard H Greiner; Brigitte Pajic-Eggspuehler; Daniel M Aebersold
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

6.  Progenitor cells in healing after pterygium excision.

Authors:  Jeong Kyu Lee; Jae Chan Kim
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

7.  Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD.

Authors:  Chun-Chi Chiang; Yi-Yu Tsai; Da-Tian Bau; Ya-Wen Cheng; Sung-Huei Tseng; Rou-Fen Wang; Fuu-Jen Tsai
Journal:  Mol Vis       Date:  2010-04-20       Impact factor: 2.367

8.  XRCC1, but not APE1 and hOGG1 gene polymorphisms is a risk factor for pterygium.

Authors:  Pei-Liang Chen; Kun-Tu Yeh; Yi-Yu Tsai; Hank Koeh; Yu-Ling Liu; Huei Lee; Ya-Wen Cheng
Journal:  Mol Vis       Date:  2010-06-04       Impact factor: 2.367

9.  Calcium-binding S100 protein expression in pterygium.

Authors:  Andri K Riau; Tina T Wong; Roger W Beuerman; Louis Tong
Journal:  Mol Vis       Date:  2009-02-16       Impact factor: 2.367

10.  Distinct gene subsets in pterygia formation and recurrence: dissecting complex biological phenomenon using genome wide expression data.

Authors:  Louis Tong; Jaime Chew; Henry Yang; Leonard P K Ang; Donald T H Tan; Roger W Beuerman
Journal:  BMC Med Genomics       Date:  2009-03-10       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.